Modification of glucocorticoid sensitivity by MAP kinase signaling pathways in glucocorticoid-induced T-cell

Tomoko Tanaka1, Taijiro Okabe, Shigeki Gondo

  • 1Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.

Experimental Hematology
|October 19, 2006
PubMed
Abstract

Insights

Mitogen-activated protein kinases (MAPKs) influence glucocorticoid sensitivity. Understanding how extracellular signal-regulated protein kinase (ERK) and p38 MAP kinase affect sensitivity may help overcome glucocorticoid resistance in patients.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Background:

  • Glucocorticoids are essential therapeutics for hematological malignancies.
  • Individual variability in glucocorticoid sensitivity and resistance presents a significant clinical challenge.
  • The precise mechanisms regulating glucocorticoid sensitivity remain incompletely understood.

Purpose of the Study:

  • To investigate the role of mitogen-activated protein kinases (MAPKs) in modulating glucocorticoid sensitivity.
  • To elucidate how specific MAPKs impact glucocorticoid-induced T-cell apoptosis.

Main Methods:

  • Utilized glucocorticoid-induced T-cell apoptosis as a model system.
  • Analyzed the effects of MAPK activation on glucocorticoid sensitivity.

Main Results:

  • Demonstrated that MAPKs significantly modify glucocorticoid sensitivity.
  • Found that extracellular signal-regulated protein kinase (ERK) activation decreases glucocorticoid sensitivity.
  • Showed that p38 MAP kinase activation enhances glucocorticoid sensitivity.

Conclusions:

  • These findings offer novel insights into the regulation of glucocorticoid sensitivity.
  • The identified MAPK pathways represent potential targets for overcoming glucocorticoid resistance.
  • This research may lead to improved therapeutic strategies for glucocorticoid-resistant conditions.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...